Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Novo Nordisk | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Novo Nordisk

Revenues up 17% in first half

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Novo Nordisk
 
1H Revenues: $6.2 billion (+17%)

1H Earnings: $1.7 billion (+22%)

Comments: Modern insulin sales increased 20% to $2.8 billion, with sales of Victoza up 82% to $717 million. Biopharmaceutical segment sales were $1.4 billion, up 6%. Sales in North America increased by 29%. International sales increased 19%.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters